---
document_datetime: 2023-09-21 17:38:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/colobreathe-epar-all-authorised-presentations_en.pdf
document_name: colobreathe-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8520202
conversion_datetime: 2025-12-20 02:06:53.846331
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength     | Pharmaceutical form             | Route of administration   | Immediate Packaging                  | Pack size                                                        |
|------------------|-------------------|--------------|---------------------------------|---------------------------|--------------------------------------|------------------------------------------------------------------|
| EU/1/11/747/001  | Colobreathe       | 1,662,500 IU | Inhalation powder, hard capsule | Inhalation use            | blister (oPA/alu/pvc/polyester/ alu) | 56 (4 x 14) capsules (blister unit) + 1 Turbospin powder inhaler |
| EU/1/11/747/002  | Colobreathe       | 1,662,500 IU | Inhalation powder, hard capsule | Inhalation use            | blister (oPA/alu/pvc/polyester/ alu) | 8 (1 x 8) capsules (blister unit + 1 Turbospin powder inhaler    |
| EU/1/11/747/003  | Colobreathe       | 1,662,500 IU | Inhalation powder, hard capsule | Inhalation use            | blister (oPA/alu/pvc/polyester/ alu) | 56 (7 x 8) capsules (blister unit) + 1 Turbospin powder inhaler  |